Regenerative Medicine Peptide Applications

# Introduction Regenerative medicine, a rapidly evolving field of medical science, focuses on the repair, replacement, and regeneration of cells, tissues, or organs to restore impaired function lost due to disease, injury, or aging [3]. Among the various approaches in regenerative medicine, the application of peptides has gained significant attention due to their potential therapeutic properties [6]. Peptides are short chains of amino acids, which are the building blocks of proteins. This review article aims to provide an overview of recent advances in the application of peptides in regenerative medicine, focusing primarily on the areas of wound healing, bone and joint diseases, and skin rejuvenation. # Preclinical Research The application of peptides in regenerative medicine has shown promising results in preclinical studies. For instance, the use of laminin 1, a high-molecular-weight glycoprotein, has been found to enhance the angiogenic and neurogenic potential of collagen-based scaffolds, thus aiding in complex wound healing applications [1]. Laminin 1's role in angiogenesis (the formation of new blood vessels) and neurogenesis (the generation of neurons) suggests its potential in improving regeneration and healing of tissues. Further, cell-free secretome of CD56(bright)CD16(bright) directly reprogrammed NK cells, a type of immune cell, have been shown to enhance wound healing via CCL3/4/5-CCR5 signaling [2]. Secretomes are the full set of molecules released by cells into the extracellular environment and play a crucial role in cell-cell communication. In another study, the delivery of Temporin-FL, an antimicrobial peptide, via mesoporous polydopamine nanoparticles was found to enhance antimicrobial penetration and accelerate healing in Staphylococcus aureus-infected wounds [7]. This research highlights the potential of peptide-loaded nanoparticles in infection management and wound healing. # Clinical Evidence In the clinical context, the use of stem cell-derived exosomes in bone and joint diseases has shown significant advancements [4]. Exosomes are small vesicles released by cells that enable intercellular communication and can carry various bioactive molecules, including peptides. Furthermore, a recombinant human collagen peptide demonstrated in vitro bioactivity in a filler biomimetic skin model [6]. This finding indicates potential applications in skin rejuvenation and the cosmetic industry. There's also evidence for the use of citrus waste-derived bioactive compounds with antioxidant and regenerative properties on human keratinocytes [5]. Keratinocytes are the predominant cell type in the outermost layer of the skin, and their regeneration is crucial for maintaining skin health. # Safety and Limitations While the potential of peptides in regenerative medicine is exciting, there are also safety considerations and limitations to consider. For instance, the safety of exogenous recombinant human platelet-derived growth factor-BB (rhPDGF-BB), a growth factor often used in regenerative medicine, has been reviewed and found to be generally safe for medical and cosmetic applications [10]. However, as with all therapies, potential side effects and individual responses need to be taken into account. The main limitation in the field of regenerative peptide therapy is the lack of extensive human trials. Most of the current evidence comes from preclinical studies, and while these provide valuable insights, they do not always translate directly to clinical practice. # Key Takeaways Peptides hold significant potential in regenerative medicine, with preclinical research showing promising results in wound healing, bone and joint diseases, and skin rejuvenation. Clinical evidence, while still limited, reinforces the potential of peptides in regenerative therapies. However, safety considerations and individual responses to therapies must be taken into account, and more human trials are needed to fully understand the potential and limitations of peptides in regenerative medicine.